Close

Prof Richard Grieve

Professor of Health Economics Methodolog

United Kingdom

I am one of the leading health economists in the UK with around 200 publications (h-index 52), and a world-wide reputation for methodological and applied research. My areas of expertise include health technology assessment (HTA), methods for generating Real World Evidence (RWE) to improve health care decision-making, and approaches to personalising interventions.
I lead a research team of health economists and statisticians undertaking health economic research of global interest. Over the last ten years I have generated total research grant income of around £70 million, and have led major studies of international relevance to successful completion and impact on policy. In 2016-7, I took the Ashridge leadership programme for senior leaders. I was the co-director of the LSHTM Centre for Statistical Methodology (CSM) (2017-22). I have held a prestigious NIHR senior research fellowship and was on the NIHR commissioning board for five years. I am an Associate Editor for a major health economics journal, Health Economics. I have delivered keynote (invited) talks to multidisciplinary audiences in the US, Canada, China, Taiwan and in the UK, and written editorials for leading clinical and health economics journals. I provide scientific advice to the UK Department of Health and to NICE. I served on the 2021 REF subpanel 2, Public Health, Health services and primary care.

Affiliations

Department of Health Services Research and Policy
Faculty of Public Health and Policy

Centres

Centre for Data and Statistical Science for Health
Global Health Economics Centre

Teaching

I currently lecture on two Masters masters delivered in term 2, economic evaluation and Evaluation of Public Health Interventions

Research

Health economics, statistical methodology, surgery, cancer, inequalities
Country
United Kingdom
United States

Selected Publications

Clinical coding of long COVID in primary care 2020-2023 in a cohort of 19 million adults: an OpenSAFELY analysis.
Henderson, AD; Butler-Cole, BF; Tazare, J; TOMLINSON, LA; MARKS, M; JIT, M; BRIGGS, A; Lin, L-Y; CARLILE, O; Bates, C; Parry, J; Bacon, SC; Dillingham, I; Dennison, WA; COSTELLO, RE; Wei, Y; Walker, AJ; Hulme, W; GOLDACRE, B; Mehrkar, A; MacKenna, B; OpenSAFELY Collaborative,; HERRETT, E; EGGO, RM;
2024
EClinicalMedicine
Comparative effectiveness of second line oral antidiabetic treatments among people with type 2 diabetes mellitus: emulation of a target trial using routinely collected health data.
BIDULKA, P; Lugo-Palacios, DG; CARROLL, O; O'NEILL, S; Adler, AI; Basu, A; Silverwood, RJ; BARTLETT, JW; NITSCH, D; Charlton, P; BRIGGS, AH; SMEETH, L; DOUGLAS, IJ; Khunti, K; GRIEVE, R;
2024
BMJ
Author Reply.
Moler-Zapata, S; HUTCHINGS, A; O'NEILL, S; Silverwood, RJ; GRIEVE, R;
2023
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
The importance of investing in data, models, experiments, team science, and public trust to help policymakers prepare for the next pandemic.
GRIEVE, R; Yang, Y; ABBOTT, S; Babu, GR; Bhattacharyya, M; Dean, N; EVANS, S; Jewell, N; Langan, SM; Lee, W; Molenberghs, G; SMEETH, L; Williamson, E; Mukherjee, B;
2023
PLOS global public health
Improving transportability of randomized controlled trial inference using robust prediction methods.
Elliott, MR; CARROLL, O; GRIEVE, R; CARPENTER, J;
2023
Statistical methods in medical research
The Evolving Nature of Health Technology Assessment: A Critical Appraisal of NICE's New Methods Manual.
ANGELIS, A; HARKER, M; CAIRNS, J; Seo, MK; LEGOOD, R; Miners, A; WISEMAN, V; Chalkidou, K; GRIEVE, R; BRIGGS, A;
2023
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
The Innovative Medicines Fund: a universal model for faster and fairer access to new promising medicines or a Trojan horse for low-value creep?
ANGELIS, A; AGGARWAL, A; Miners, A; GRIEVE, R; CAIRNS, J; BRIGGS, A;
2023
Journal of the Royal Society of Medicine
See more information